Characterization of histamine-releasing activity: Role of cytokines and IgE heterogeneity
- 1 July 1992
- journal article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 12 (4) , 248-258
- https://doi.org/10.1007/bf00918148
Abstract
Histamine-releasing factors (HRFs) are a group of cytokines that cause histamine release (HR) from basophils and mast cells. The concept of the priming effect of cytokines and the heterogeneity of IgE involved in the HRF-induced HR have been emphasized in recent years. In this study, we performed a series of experiments to elucidate the above-mentioned hypotheses. The stock HRF were obtained by stimulating mononuclear cells (MNC) with phytohemagglutinin (PHA). Maximal activity was observed 36 hr after culture. By gel filtration, HRF was eluted with a peak activity ranging from 12 to 18 KD. A large portion (75%) of HRF activity could be neutralized by a combination of antibodies against interleukin 1 (IL-1), IL-3, IL-8, granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor-alpha (TNF-α). The stimulation of basophils with 100 ng/ml each of IL-3, IL-6, IL-7, GM-CSF, or TNF-α alone caused 10% HR; however, when the cells were pretreated with 10 ng/ml of either IL-3, IL-6, IL-7, IL-8, TNF-α, or GM-CSF and then stimulated with anti-IgE, a marked increase in HR was regularly observed. The combination of 100 ng/ml each of IL-1, IL-3, IL-8, GM-CSF, and TNF-α could induce only about 20% HR; furthermore, such combinations did not have an additive or synergistic priming effect on anti-IgE-induced HR compared to the effect of single cytokines. Stripping of surface-bound IgE with lactic acid markedly reduced the capacity of basophils to release histamine in response to MNC-HRF and anti-IgE. Passive sensitization of IgE-stripped basophils with high-HRF responders' serum could restore their responsiveness to both MNC-HRF and anti-IgE, but passive sensitization with low-HRF responders' serum could restore responsiveness to anti-IgE only. Moreover, passage of MNC-HRF through high-, but not low-HRF, responders' IgE-Sepharose columns significantly reduced the HR activity of MNC-HRF. Finally, although the eluant could induce only 10% HR, the majority of its HR activity could be restored by the addition of effluent but not by the mixture of IL-1, IL-3, IL-8, GM-CSF, and TNF-α, suggesting the presence of a complex interaction among those cytokines. In summary, MNC-HRF contained at least two types of HRF activity; one was IgE dependent and the other was IgE independent. Cytokines such as IL-1, IL-3, IL-8, GM-CSF, and TNF-α showed a priming effect on histamine release induced by MNC-HRF, although another unidentified cytokine(s) may be also involved.Keywords
This publication has 43 references indexed in Scilit:
- Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists.The Journal of Experimental Medicine, 1990
- Altered production of histamine-releasing factor (HRF) activity and responsiveness to HRF after immunotherapy in children with asthmaJournal of Allergy and Clinical Immunology, 1990
- Enhancement of human basophil histamine release by interleukin 5.The Journal of Experimental Medicine, 1990
- Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine-activated killer cells from human peripheral blood.The Journal of Experimental Medicine, 1990
- Sensitivity of basophils to histamine releasing factor(s) of various origin: Dependency on allergic phenotype of the donor and surface-bound IgEJournal of Allergy and Clinical Immunology, 1990
- Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III.Journal of Clinical Investigation, 1990
- Murine interleukin 7 (IL-7) receptor. Characterization on an IL-7-dependent cell line.The Journal of Experimental Medicine, 1990
- The effect of preseasonal immunotherapy on the production of histamine-refeasing factor (HRF) by mononuclear cells from patients with seasonal asthma: Results of a double-blind, placebo-controlled, randomized studyJournal of Allergy and Clinical Immunology, 1989
- New Perspectives in the Modulation of Allergic InflammationInternational Archives of Allergy and Immunology, 1989
- Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release.Journal of Clinical Investigation, 1988